Mesoblast Stock Jumps on Ryoncil Milestone – Analysts See 40% Upside Mesoblast’s stock has surged recently on the Ryoncil news. At the Oct 2 close it stood at $17.02 – up +4.6% on the day and roughly +8% from two weeks prior stockinvest.us 3 October 2025 Analyst Ratings · Biotech · Investing · Market News · NASDAQ:MSB · Stock Market · Stocks
